Novel Biomarkers Of Treatment-Induced Muscle Damage, Exercise And Fatigue: An RCT In Breast Cancer Patients
Karen M. Mustian(University of Rochester Medical Center), Gary R. Morrow(University of Rochester Medical Center), Richard F. Dunne(University of Rochester), Luke J. Peppone(University of Rochester Medical Center), Erika Ramsdale(University of Rochester Medicine), Julia E. Inglis(University of Rochester Medicine), Charles Kamen(University of Rochester), Kah Poh Loh(University of Pavia), Charles E. Heckler(University of Rochester Medicine), Michelle Porto(University of Rochester), Nikesha Gilmore(University of Rochester), Chunkit Fung(Oslo University Hospital), Michelle C. Janelsins(University of Rochester), Ian R. Kleckner(University of Maryland, College Park), Ann Colasurdo(University of Rochester Medicine), Eva Culakova(University of Rochester), Amber S. Kleckner(University of Maryland, Baltimore), Gilberto López(University of Rochester Medicine), Po‐Ju Lin(University of Rochester Medicine)
Cited by 0
Related Papers
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Applied Discriminant Analysis
|Technometrics|1995|409